These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38599316)

  • 1. Unravelling the in vivo dynamics of liposomes: Insights into biodistribution and cellular membrane interactions.
    Paramshetti S; Angolkar M; Talath S; Osmani RAM; Spandana A; Al Fatease A; Hani U; Ramesh KVRNS; Singh E
    Life Sci; 2024 Jun; 346():122616. PubMed ID: 38599316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate.
    Sheikholeslami B; Lam NW; Dua K; Haghi M
    Life Sci; 2022 Jul; 300():120574. PubMed ID: 35469915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Sojourn on Liposomal Delivery System: Recent Advances and Future Prospects.
    Kaur S; Singh D
    Assay Drug Dev Technol; 2023; 21(2):48-64. PubMed ID: 36856471
    [No Abstract]   [Full Text] [Related]  

  • 4. Liposomes of Quantum Dots Configured for Passive and Active Delivery to Tumor Tissue.
    Aizik G; Waiskopf N; Agbaria M; Ben-David-Naim M; Levi-Kalisman Y; Shahar A; Banin U; Golomb G
    Nano Lett; 2019 Sep; 19(9):5844-5852. PubMed ID: 31424944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and Challenges of Liposome Assisted Drug Delivery.
    Sercombe L; Veerati T; Moheimani F; Wu SY; Sood AK; Hua S
    Front Pharmacol; 2015; 6():286. PubMed ID: 26648870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future directions of liposome- and immunoliposome-based cancer therapeutics.
    Park JW; Benz CC; Martin FJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of liposomes as drug delivery system for therapeutic applications.
    Guimarães D; Cavaco-Paulo A; Nogueira E
    Int J Pharm; 2021 May; 601():120571. PubMed ID: 33812967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin.
    Mamasheva E; O'Donnell C; Bandekar A; Sofou S
    Mol Pharm; 2011 Dec; 8(6):2224-32. PubMed ID: 21899300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.
    Zylberberg C; Matosevic S
    Drug Deliv; 2016 Nov; 23(9):3319-3329. PubMed ID: 27145899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast, Efficient, and Targeted Liposome Delivery Mediated by DNA Hybridization.
    Li H; Liu Q; Crielaard BJ; de Vries JW; Loznik M; Meng Z; Yang X; Göstl R; Herrmann A
    Adv Healthc Mater; 2019 Jul; 8(14):e1900389. PubMed ID: 31081288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications.
    Hua S; Vaughan B
    Int J Nanomedicine; 2019; 14():2191-2206. PubMed ID: 30988616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.
    Ranade VV
    J Clin Pharmacol; 1989 Aug; 29(8):685-94. PubMed ID: 2674208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.
    Kesharwani P; Kumari K; Gururani R; Jain S; Sharma S
    Curr Drug Metab; 2022; 23(9):678-692. PubMed ID: 35692131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.
    Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
    Int J Nanomedicine; 2019; 14():6497-6517. PubMed ID: 31616141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain.
    Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
    J Pharmacol Exp Ther; 2020 Sep; 374(3):354-365. PubMed ID: 32561686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A review on the influences of size and surface charge of liposome on its targeted drug delivery in vivo].
    Yang YF; Xie XY; Yang Y; Zhang H; Mei XG
    Yao Xue Xue Bao; 2013 Nov; 48(11):1644-50. PubMed ID: 24475700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.
    Dézsi L; Fülöp T; Mészáros T; Szénási G; Urbanics R; Vázsonyi C; Őrfi E; Rosivall L; Nemes R; Kok RJ; Metselaar JM; Storm G; Szebeni J
    J Control Release; 2014 Dec; 195():2-10. PubMed ID: 25148822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution.
    Flaten GE; Chang TT; Phillips WT; Brandl M; Bao A; Goins B
    J Liposome Res; 2013 Mar; 23(1):70-81. PubMed ID: 23210622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal antibiotics for the treatment of infectious diseases.
    Alhariri M; Azghani A; Omri A
    Expert Opin Drug Deliv; 2013 Nov; 10(11):1515-32. PubMed ID: 23886421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.